In the second part of this roundtable discussion, participants highlight best practices for reaching underrepresented populations and increasing their awareness of clinical trials. Post navigation Two-Year Phase III Data Confirm Long-Term Efficacy, Safety of Bimzelx in Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, Ankylosing Spondylitis DREAMM-7 Trial Shows Blenrep Combo Significantly Boosts Overall Survival in Relapsed/Refractory Multiple Myeloma